MedPath

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

Not Applicable
Recruiting
Conditions
Youth
Insomnia
Anxiety
Interventions
Behavioral: CBT-I
Behavioral: CBT-I combined ACT
Registration Number
NCT06156306
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

Insomnia in adolescents and youth is a long-standing public health concern due to its high prevalence and association with various physical and mental health problems. Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. CBT for insomnia (CBT-I) has been shown to be effective in improving sleep complaints and short-term improvement in mood while previous systematic reviews of interventional studies have demonstrated the effectiveness of acceptance and commitment therapy (ACT) interventions in treating insomnia, both as a primary condition and with other physical and/or mental health comorbidities. This study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth.

Detailed Description

Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. Moreover, approximately three-quarters of anxious youth also report sleep-related problems. Literature reviews have investigated the relationship and the shared underlying mechanisms between sleep and anxiety. Anxiety sensitivity and pre-sleep arousal have been found to play a critical role in difficulty initiating sleep, which is the most common insomnia symptoms in adolescent population, partially due their natural delay of circadian rhythm. The findings suggest shared neurological and cognitive features that may account for dysregulation of both sleep and affect. Management targeting both sleep and anxiety is recommended due to potentially higher treatment efficacy and cost-effectiveness.

Accumulating evidence supports the effectiveness of cognitive-behavioural therapy for insomnia (CBT-I) and acceptance and commitment therapy (ACT) for addressing sleep and mood problems in adolescents. However, Only a few studies have directly compared the effectiveness of CBT-I and ACT. Past studies have shown that both CBT-I and ACT were effective in treating insomnia in adults.

This current study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth. The primary hypothesis is that subjects in CBT-I combined ACT will have fewer anxiety symptoms as compared to CBT-I at post-intervention and 3-month follow-up.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Youth who meet the following criteria would be eligible for taking part in this trial:

i. Chinese youth aged 15-24 years old, ii. Presence of insomnia problems as defined by insomnia severity index (ISI) using cut-off of 9, which has been locally validated cut off for detecting clinical insomnia), iii. Presence of anxiety features as defined by General Anxiety Disorder-7 (GAD-7) using cut-off of 10 for detecting clinical anxiety, iv. Ability to listen, speak, and read Chinese and Cantonese, and v. Written informed consent of participation into the study is given by youth and his/her parent's if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old vi. Possession of smartphone

Read More
Exclusion Criteria

A youth would be excluded from the study if meeting one or more of the following criteria:

i. A clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual disability ii. Having a diagnosed sleep disorder (e.g. delayed sleep phase and narcolepsy) that may potentially contribute to the disruption of sleep quantity and quality as determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP) iii. Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt) as assessed by The Structured Clinical Interview (SCID) iv. Currently receiving psychological treatment and/or pharmacological treatment for insomnia or anxiety disorder.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CBT-ICBT-IA total of 6 sessions of face-to-face group CBT-I therapy will be provided. Each session will last 90-120 mins, with each group 8-10 subjects.
CBT-I combined ACTCBT-I combined ACTA total of 6 sessions of face-to-face group CBT-I+ACT therapy will be provided. Each session will last 90-120 mins, with each group 8-10 subjects.
Primary Outcome Measures
NameTimeMethod
Severity of anxiety symptomsBaseline, Postintervention (6 weeks), and 3-month follow up

Hospital Anxiety and Depression Scale (HADS) will be used to assess anxiety symptoms.

Clinician-rated severity of anxiety symptomsBaseline, Postintervention (6 weeks), and 3-month follow up

Hamilton Anxiety Rating Scale (HAM-A) will be used to assess anxiety symptoms.

Severity of anxiety symptoms and severityBaseline, Postintervention (6 weeks), and 3-month follow up

General Anxiety Disorder-7 (GAD-7) will be used to assess anxiety symptoms and severity.

Secondary Outcome Measures
NameTimeMethod
Frequency of an individual practice sleep hygieneBaseline, Postintervention (6 weeks), and 3-month follow up

Sleep Hygiene Practice Scale (SHPS) will be used to measure the frequency of an individual practice sleep hygiene.

Individual's state of arousalBaseline, Postintervention (6 weeks), and 3-month follow up

Pre-Sleep Arousal Scale (PSAS) will be used to measure individual's state of arousal as one falls asleep.

Faulty sleep-related beliefs and cognitionsBaseline, Postintervention (6 weeks), and 3-month follow up

Dysfunctional Beliefs and Attitudes about Sleep Scale-16-item (DBAS-16) will be used to measure faulty sleep-related beliefs and cognitions, which are cognitive aspects typically involved in the maintenance of insomnia.

Severity of insomnia symptomsBaseline, Postintervention (6 weeks), and 3-month follow up

Insomnia Severity Index (ISI) will be used to measure the severity of insomnia symptoms.

Anxiety traitBaseline, Postintervention (6 weeks), and 3-month follow up

The State-Trait Anxiety Inventory (STAI) will be used to measure anxiety trait

Severity of depressive symptomsBaseline, Postintervention (6 weeks), and 3-month follow up

Patient Health Questionnaire 9-item (PHQ-9) will be used to measure the severity of depressive symptoms.

Sleep-wake patternBaseline, Postintervention (6 weeks), and 3-month follow up

Youths will be asked to keep a sleep diary to chart their daily sleep-wake pattern including sleep duration, wakeup time, bedtime and sleep latency

Daytime sleepinessBaseline, Postintervention (6 weeks), and 3-month follow up

Pediatric Daytime Sleepiness Scale (PDSS) will be used to assess adolescents' daytime sleepiness.

Psychological flexibility and experiential avoidanceBaseline, Postintervention (6 weeks), and 3-month follow up

Acceptance and Action Questionnaire-II (AAQ-II) is related to the underlying ACT theory to measure psychological flexibility and experiential avoidance.

Tendency to ruminateBaseline, Postintervention (6 weeks), and 3-month follow up

The Ruminative Responses Scale - short version (RRS-10) is a 10-item scale on a 4-likert scale. It measures the tendency to ruminate.

Major life events and hasslesBaseline, Postintervention (6 weeks), and 3-month follow up

The Adolescent Stress Index (ASI), which was developed using a Hong Kong student sample, will be used to measure major life events and hassles

Global cognitive appraisal of one's life satisfactionBaseline, Postintervention (6 weeks), and 3-month follow up

The Satisfaction With Life Scale (SWLS): SWLS is a 5-item scale on a 7-Likert scale. It measures the global cognitive appraisal of one's life satisfaction.

Subjective well-being in the previous weekBaseline, Postintervention (6 weeks), and 3-month follow up

The International Positive and Negative Affect Schedule Short Form (IPANAS-SF) will be used to capture the subjective well-being in the previous week. It has 9 items on a 5-Likert scale with previous study demonstrating satisfactory internal consistency reliability and reasonable nomological validity in Chinese youth.

Trial Locations

Locations (1)

Department of Psychiatry, the Chinese University of Hong Kong

🇭🇰

Sha Tin, New Territories, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath